The drugmaker said the results for giredestrant open the door to adding a treatment option at an early stage of the cancer, ...

Roche's experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

By embedding standardized questionnaires and algorithms into routine visits, providers can evaluate risk factors such as age, ...

The rationale is really strong since we're often making decisions for our patients based on single features or ...

Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an ...

When fashion model Christine Handy was diagnosed with breast cancer at 41, she turned to movies for answers. What she found ...

The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

You can help in the fight against breast cancer by participating in the Mary Bird Perkins Cancer Center’s Geaux Pink ...

A new law is providing better access to breast cancer screenings for Oklahomans. 2 News’ Naomi Keitt listened to experts to ...

A 4-year-old boy was diagnosed with a rare brain cancer, only five months before his mother was also diagnosed with cancer.